NCT00920361已完成不适用
Designated Drug Use Investigation 1 of Follistim Injection
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,664
- 主要终点
- Number of retrieved oocytes
研究概览
简要总结
To evaluate dosage and administration method, efficacy and safety of Puregon and the relationship between background factors of patients and dose and administration method.
Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients who underwent IVF
排除标准
- •Patients with tumors of ovary, breast, uterus, pituitary or hypothalamus
- •Pregnant or possible pregnant women, or lactating women
- •Patients with undiagnosed atypical vaginal bleeding
- •Patients with a history of hypersensitivity to any of the ingredients of this product.
- •Patients with ovarian cysts or enlarged ovaries, not related to polycystic ovarian disease
研究组 & 干预措施
1
Patients who underwent IVF
干预措施: Follitropin beta (Drug)
结局指标
主要结局
Number of retrieved oocytes
时间窗: 2 months, from initiation of treatment to confirmation of pregnancy.
次要结局
- Pregnancy outcome(2 months, from initiation of treatment to confirmation of pregnancy.)
研究者
相似试验
已完成
不适用
Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)AnovulationNCT00920634Organon and Co384
已完成
1 期
A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial InfarctionAcute Myocardial InfarctionNCT00215124The Cleveland Clinic
已完成
3 期
Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in HypertensionHypertensionNCT05820880Institut de Recherches Internationales Servier532
终止
1 期
A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly VolunteersHealthyElderlyNCT00736528Pfizer10
已完成
1 期
A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine InjectionMCIADNCT06593626HTA Co., Ltd.28